These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 15954850)

  • 1. Sertaconazole: updated review of a topical antifungal agent.
    Carrillo-Muñoz AJ; Giusiano G; Ezkurra PA; Quindós G
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):333-42. PubMed ID: 15954850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of in vitro activity of sertaconazole nitrate in the treatment of superficial fungal infections.
    Pfaller MA; Sutton DA
    Diagn Microbiol Infect Dis; 2006 Oct; 56(2):147-52. PubMed ID: 16822638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertaconazole: a review of its use in the management of superficial mycoses in dermatology and gynaecology.
    Croxtall JD; Plosker GL
    Drugs; 2009; 69(3):339-59. PubMed ID: 19275277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sertaconazole: an antifungal agent for the topical treatment of superficial candidiasis.
    Carrillo-Muñoz AJ; Tur-Tur C; Giusiano G; Marcos-Arias C; Eraso E; Jauregizar N; Quindós G
    Expert Rev Anti Infect Ther; 2013 Apr; 11(4):347-58. PubMed ID: 23566144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sertaconazole in the treatment of mycoses: from dermatology to gynecology.
    Torres J; Márquez M; Camps F
    Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S3-20. PubMed ID: 11118560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sertaconazole: pharmacology of a gynecological antifungal agent.
    Palacín C; Tarragó C; Ortiz JA
    Int J Gynaecol Obstet; 2000 Dec; 71 Suppl 1():S37-46. PubMed ID: 11118563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
    Agut J; Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of sertaconazole.
    Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):699-705. PubMed ID: 1627186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertaconazole (FI-7045). A new antifungal agent. Introduction.
    Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):689-90. PubMed ID: 1627183
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of cutaneous dermatophytosis.
    Pedragosa R; González B; Martín M; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):760-3. PubMed ID: 1627202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiinflammatory activity of topically applied sertaconazole nitrate.
    Agut J; Tarrida N; Sacristán A; Ortiz JA
    Methods Find Exp Clin Pharmacol; 1996 May; 18(4):233-4. PubMed ID: 8803954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive management of patients with superficial fungal infections: the role of sertaconazole nitrate.
    Del Rosso JQ
    Cutis; 2008 Jun; 81(6 Suppl):4-18; quiz 19-20. PubMed ID: 18693645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory and anti-itch activity of sertaconazole nitrate.
    Liebel F; Lyte P; Garay M; Babad J; Southall MD
    Arch Dermatol Res; 2006 Sep; 298(4):191-9. PubMed ID: 16868738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertaconazole 2% cream vs. miconazole 2% cream for cutaneous mycoses: a double-blind clinical trial.
    Ghaninejad H; Gholami K; Hashemi P; Hajibabai M; Rahbar Z; Farivar MS; Mastani F; Rashidi A
    Clin Exp Dermatol; 2009 Dec; 34(8):e837-9. PubMed ID: 19793095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of Pityriasis versicolor.
    Nasarre J; Umbert P; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):764-7. PubMed ID: 1627203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of the therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of superficial mycoses caused by Candida albicans.
    Umbert P; Nasarre J; Bello A; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):757-60. PubMed ID: 1627201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses.
    Romaguera C; Herrero E; Márquez M; Torres J; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):754-6. PubMed ID: 1627200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sertaconazole in the treatment of pediatric patients with cutaneous dermatophyte infections.
    Van Esso D; Fajo G; Losada I; Vilallonga M; Casanovas JM; Clanxet J; Aliaga A
    Clin Ther; 1995; 17(2):264-9. PubMed ID: 7614526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses.
    Alomar C; Bassas S; Casas M; Crespo V; Ferrándiz C; Fonseca E; Hernández B; Noguera J; Pedragosa R; Peyrí J
    Arzneimittelforschung; 1992 May; 42(5A):767-73. PubMed ID: 1627204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sertaconazole antifungal profile determined by a microdilution method versus nine topical substances against dermatophyte fungi.
    Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G
    Chemotherapy; 2012; 58(5):399-404. PubMed ID: 23296325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.